PSU Profiles
Keywords
Last Name
Institution

David Goldenberg

TitleProfessor
InstitutionCollege of Medicine
DepartmentSurgery
Address500 University Drive Hershey PA 17033
Phone7175318945
Other Positions
TitleProfessor
InstitutionCollege of Medicine
DepartmentOncology


 Overview 
 overview
PREFERRED TITLE/ROLE:



Professor of Surgery and Oncology, Director of Head and Neck Surgery



EDUCATION:



Fellowship, Head & Neck Oncology and Surgery: The Johns Hopkins University Hospital, Baltimore (2005)

Residency, Rambam Medical Center, Haifa Israel (2002)

Internship, Soroka Medical Center, Beer Sheva Israel (1996)

M.D., Ben Gurion University of the Negev,Beer Sheva Israel (1994)



NARRATIVE:



David Goldenberg is a Head and Neck Surgical Oncologist. He was educated at the Ben Gurion University in Israel. He completed a residency in Otolaryngology-Head and Neck Surgery at Rambam Medical Center in Haifa, Israel and then went on to do a three year fellowship in Head and Neck Surgery and Oncology at the Johns Hopkins Hospital in Baltimore. Currently a Professor of both Surgery and Oncology at the Penn State College of Medicine, he serves as the director of Head and Neck Surgery at the Penn State Hershey Medical Center and director of the Head and Neck Cancer Team at the Penn State Cancer Institute in Hershey, PA. He combines a surgical practice with teaching and research in head and neck and thyroid malignancies.



Clinical expertise is in the surgical care of patients with head and neck cancer, thyroid cancer as well as parathyroid disease. Dr. Goldenberg is the only head and neck surgeon in the region performing Da Vinci TransOral Robotic Surgery (TORS) and Minimally invasive radioguided parathyroidecotmy (MIRP).



Research: Dr. Goldenberg is an NIH funded researcher and a prolific author of articles and books in the field of head and neck and thyroid oncology and surgery.


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Magreni A, Bann DV, Schubart JR, Goldenberg D. The effects of race and ethnicity on thyroid cancer incidence. JAMA Otolaryngol Head Neck Surg. 2015 Apr 1; 141(4):319-23.
    View in: PubMed
  2. Bann DV, Zacharia T, Goldenberg D, Goyal N. Parathyroid localization using 4D-computed tomography. Ear Nose Throat J. 2015 Apr-May; 94(4-5):E55-7.
    View in: PubMed
  3. Sharma J, Goldenberg D, Crist H, McGinn J. Multifocal inverted papillomas in the head and neck. Ear Nose Throat J. 2015 Mar; 94(3):E20-3.
    View in: PubMed
  4. Goyal N, Goldenberg D. Reply to Letter to the Editor regarding course of lingual artery. Head Neck. 2015 Mar; 37(3):461-2.
    View in: PubMed
  5. Patel HH, Siltumens A, Bess L, Camacho F, Goldenberg D. The Decline of Tracheotomy among Otolaryngologists: A 14-Year Review. Otolaryngol Head Neck Surg. 2015 Mar; 152(3):465-9.
    View in: PubMed
  6. Roman BR, Patel SG, Wang MB, Pou AM, Holsinger FC, Myssiorek D, Goldenberg D, Swisher-McClure S, Lin A, Shah JP, Shea JA. Guideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancer. J Natl Compr Canc Netw. 2015 Jan; 13(1):69-77.
    View in: PubMed
  7. Goldenberg D, Goyal N. Guest EditorialImpact factor: What is it and is it still relevant? [Editorial]. Ear Nose Throat J. 2015 Jan; 94(1):14-9.
    View in: PubMed
  8. Adil E, Setabutr D, Ghossaini SN, Goldenberg D. Metastatic squamous cell carcinoma of the tonsil presenting as otorrhea: A case report. Ear Nose Throat J. 2015 Jan; 94(1):E7-9.
    View in: PubMed
  9. Bann DV, Goyal N, Camacho F, Goldenberg D. Increasing incidence of thyroid cancer in the commonwealth of pennsylvania. JAMA Otolaryngol Head Neck Surg. 2014 Dec 1; 140(12):1149-56.
    View in: PubMed
  10. Payne SJ, Smucker JE, Bruno MA, Winner LS, Saunders BD, Goldenberg D. Radiographic evaluation of non-localizing parathyroid adenomas. Am J Otolaryngol. 2015 Mar-Apr; 36(2):217-22.
    View in: PubMed
  11. Bann DV, Goyal N, Crist H, Goldenberg D. Black thyroid. Ear Nose Throat J. 2014 Oct-Nov; 93(10-11):E54-5.
    View in: PubMed
  12. Goldenberg DM, Rooney RJ, Loo M, Liu D, Chang CH. In-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA. PLoS One. 2014; 9(9):e107927.
    View in: PubMed
  13. Goldenberg D, Mackley H, Koch W, Bann DV, Schaefer EW, Hollenbeak CS. Age and stage as determinants of treatment for oral cavity and oropharyngeal cancers in the elderly. Oral Oncol. 2014 Oct; 50(10):976-82.
    View in: PubMed
  14. Goyal N, Camacho F, Mangano J, Goldenberg D. Evaluating for a geospatial relationship between radon levels and thyroid Cancer in Pennsylvania. Laryngoscope. 2015 Jan; 125(1):E45-9.
    View in: PubMed
  15. Patel HH, Goyal N, Goldenberg D. Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer. Ann Med. 2014 Sep; 46(6):409-16.
    View in: PubMed
  16. Bann DV, Goyal N, Goldenberg D. Papillary thyroid cancer in a gravid woman. Ear Nose Throat J. 2014 Jul; 93(7):252-4.
    View in: PubMed
  17. Sgouros G, Goldenberg DM. Radiopharmaceutical therapy in the era of precision medicine. Eur J Cancer. 2014 Sep; 50(13):2360-3.
    View in: PubMed
  18. Schaefer EW, Wilson MZ, Goldenberg D, Mackley H, Koch W, Hollenbeak CS. Effect of marriage on outcomes for elderly patients with head and neck cancer. Head Neck. 2015 May; 37(5):735-42.
    View in: PubMed
  19. Shah S, Goldenberg D. Robotic surgery for oropharyngeal cancer. Rambam Maimonides Med J. 2014 Apr; 5(2):e0014.
    View in: PubMed
  20. Bann DV, Goyal N, Goldenberg D. Parathyroid adenoma in a woman with secondary hyperparathyroidism. Ear Nose Throat J. 2014 Apr-May; 93(4-5):158, 160.
    View in: PubMed
  21. Shi C, Merchant N, Newsome G, Goldenberg DM, Gold DV. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry. Arch Pathol Lab Med. 2014 Feb; 138(2):220-8.
    View in: PubMed
  22. Goyal N, Yoo F, Setabutr D, Goldenberg D. Surgical anatomy of the supraglottic larynx using the da Vinci robot. Head Neck. 2014 Aug; 36(8):1126-31.
    View in: PubMed
  23. Strand V, Petri M, Kalunian K, Gordon C, Wallace DJ, Hobbs K, Kelley L, Kilgallen B, Wegener WA, Goldenberg DM. Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006. Rheumatology (Oxford). 2014 Mar; 53(3):502-11.
    View in: PubMed
  24. Oberman B, Setabutr D, Goldenberg D. Traumatic dislocation of intact mandibular condyle into middle cranial fossa. Am J Otolaryngol. 2014 Mar-Apr; 35(2):251-3.
    View in: PubMed
  25. Yoo F, Chaikhoutdinov I, Mitzner R, Liao J, Goldenberg D. Characteristics of incidentally discovered thyroid cancer. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1181-6.
    View in: PubMed
  26. Malloy KM, Ellender SM, Goldenberg D, Dolan RW. A survey of current practices, attitudes, and knowledge regarding human papillomavirus-related cancers and vaccines among head and neck surgeons. JAMA Otolaryngol Head Neck Surg. 2013 Oct; 139(10):1037-42.
    View in: PubMed
  27. Lynch MC, Baker A, Drabick JJ, Williams N, Goldenberg D. Extraskeletal Ewing's sarcoma arising in the larynx. Head Neck Pathol. 2014 Jun; 8(2):225-8.
    View in: PubMed
  28. Abdulghani J, Allen JE, Dicker DT, Liu YY, Goldenberg D, Smith CD, Humphreys R, El-Deiry WS. Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis. PLoS One. 2013; 8(9):e75414.
    View in: PubMed
  29. Boltz MM, Hollenbeak CS, Schaefer E, Goldenberg D, Saunders BD. Attributable costs of differentiated thyroid cancer in the elderly Medicare population. Surgery. 2013 Dec; 154(6):1363-9; discussion 1369-70.
    View in: PubMed
  30. Crist HS, Evans JJ, Mani H, Saunders B, Fornadley J, Camacho F, Goldenberg D. Do black (dark) lymph-node metastases in papillary thyroid carcinoma suggest more advanced or aggressive disease? Thyroid. 2013 Aug; 23(8):977-81.
    View in: PubMed
  31. Liebman HA, Saleh MN, Bussel JB, Negrea OG, Horne H, Wegener WA, Goldenberg DM. Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study. Br J Haematol. 2013 Sep; 162(5):693-701.
    View in: PubMed
  32. Wallace DJ, Gordon C, Strand V, Hobbs K, Petri M, Kalunian K, Houssiau F, Tak PP, Isenberg DA, Kelley L, Kilgallen B, Barry AN, Wegener WA, Goldenberg DM. Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up. Rheumatology (Oxford). 2013 Jul; 52(7):1313-22.
    View in: PubMed
  33. Hollenbeak CS, Boltz MM, Schaefer EW, Saunders BD, Goldenberg D. Recurrence of differentiated thyroid cancer in the elderly. Eur J Endocrinol. 2013 Apr; 168(4):549-56.
    View in: PubMed
  34. Ho Y, Carr MM, Goldenberg D. Trends in intraoperative neural monitoring for thyroid and parathyroid surgery amongst otolaryngologists and general surgeons. Eur Arch Otorhinolaryngol. 2013 Sep; 270(9):2525-30.
    View in: PubMed
  35. Goyal N, Setabutr D, Abdulghani J, Goldenberg D. Molecular and genetic markers of follicular-cell thyroid cancer: etiology and diagnostic and therapeutic opportunities. Adv Exp Med Biol. 2013; 779:309-26.
    View in: PubMed
  36. Chaikhoutdinov I, Goldenberg D. Impact of genetic targets on therapy in head and neck squamous cell carcinoma. Adv Exp Med Biol. 2013; 779:165-77.
    View in: PubMed
  37. Baker AR, Ohanessian SE, Adil E, Crist HS, Goldenberg D, Mani H. Dedifferentiated epithelial-myoepithelial carcinoma: analysis of a rare entity based on a case report and literature review. Int J Surg Pathol. 2013 Oct; 21(5):514-9.
    View in: PubMed
  38. Warshafsky D, Goldenberg D, Kanekar SG. Imaging anatomy of deep neck spaces. Otolaryngol Clin North Am. 2012 Dec; 45(6):1203-21.
    View in: PubMed
  39. Chen X, Chang CH, Stein R, Cardillo TM, Gold DV, Goldenberg DM. Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab. Biol Blood Marrow Transplant. 2013 Jan; 19(1):28-39.
    View in: PubMed
  40. Sharkey RM, van Rij CM, Karacay H, Rossi EA, Frielink C, Regino C, Cardillo TM, McBride WJ, Chang CH, Boerman OC, Goldenberg DM. A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers. J Nucl Med. 2012 Oct; 53(10):1625-32.
    View in: PubMed
  41. Chang SS, Goldenberg D, Koch WM. Transcervical approach to benign parapharyngeal space tumors. Ann Otol Rhinol Laryngol. 2012 Sep; 121(9):620-4.
    View in: PubMed
  42. Goyal N, Zacharia TT, Goldenberg D. Differentiation of branchial cleft cysts and malignant cystic adenopathy of pharyngeal origin. AJR Am J Roentgenol. 2012 Aug; 199(2):W216-21.
    View in: PubMed
  43. Evans JJ, Crist HS, Durvesh S, Bruggeman RD, Goldenberg D. A comparative study of cell cycle mediator protein expression patterns in anaplastic and papillary thyroid carcinoma. Cancer Biol Ther. 2012 Jul; 13(9):776-81.
    View in: PubMed
  44. Garritano FG, Goldenberg D. Telemedicine in otolaryngology-head and neck surgery. Ear Nose Throat J. 2012 Jun; 91(6):226-9.
    View in: PubMed
  45. Ocean AJ, Pennington KL, Guarino MJ, Sheikh A, Bekaii-Saab T, Serafini AN, Lee D, Sung MW, Gulec SA, Goldsmith SJ, Manzone T, Holt M, O'Neil BH, Hall N, Montero AJ, Kauh J, Gold DV, Horne H, Wegener WA, Goldenberg DM. Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial. Cancer. 2012 Nov 15; 118(22):5497-506.
    View in: PubMed
  46. Goyal N, Camacho F, Mangano J, Goldenberg D. Thyroid cancer characteristics in the population surrounding Three Mile Island. Laryngoscope. 2012 Jun; 122(6):1415-21.
    View in: PubMed
  47. Goldenberg DM. Horizontal transmission of malignancy by cell-cell fusion. Expert Opin Biol Ther. 2012 Jun; 12 Suppl 1:S133-9.
    View in: PubMed
  48. Taylor AP, Makabi-Panzu B, Chen X, Gold DV, Goldenberg DM. Evaluation of a non-viral vaccine in smallpox-vaccinated individuals and immunized HLA-transgenic mice. Hum Immunol. 2012 Jun; 73(6):612-9.
    View in: PubMed
  49. Stack BC, Ferris RL, Goldenberg D, Haymart M, Shaha A, Sheth S, Sosa JA, Tufano RP. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid. 2012 May; 22(5):501-8.
    View in: PubMed
  50. Frölich D, Blassfeld D, Reiter K, Giesecke C, Daridon C, Mei HE, Burmester GR, Goldenberg DM, Salama A, Dörner T. The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression. Arthritis Res Ther. 2012; 14(2):R54.
    View in: PubMed
  51. Sharkey RM, Chang CH, Rossi EA, McBride WJ, Goldenberg DM. Pretargeting: taking an alternate route for localizing radionuclides. Tumour Biol. 2012 Jun; 33(3):591-600.
    View in: PubMed
  52. Adil E, Setabutr D, Mikesell K, Goldenberg D. Hyalinizing clear cell adenocarcinoma of the oropharynx. Head Neck. 2013 Jun; 35(6):E184-6.
    View in: PubMed
  53. Alinari L, Mahoney E, Patton J, Zhang X, Huynh L, Earl CT, Mani R, Mao Y, Yu B, Quinion C, Towns WH, Chen CS, Goldenberg DM, Blum KA, Byrd JC, Muthusamy N, Praetorius-Ibba M, Baiocchi RA. FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death. Blood. 2011 Dec 22; 118(26):6893-903.
    View in: PubMed
  54. Garritano FG, Goldenberg D. Successful telemedicine programs in otolaryngology. Otolaryngol Clin North Am. 2011 Dec; 44(6):1259-74, vii.
    View in: PubMed
  55. Tashima L, Mitzner R, Durvesh S, Goldenberg D. Dyspnea as a prognostic factor in anaplastic thyroid carcinoma. Eur Arch Otorhinolaryngol. 2012 Apr; 269(4):1251-5.
    View in: PubMed
  56. Rossi EA, Rossi DL, Cardillo TM, Stein R, Goldenberg DM, Chang CH. Preclinical studies on targeted delivery of multiple IFNa2b to HLA-DR in diverse hematologic cancers. Blood. 2011 Aug 18; 118(7):1877-84.
    View in: PubMed
  57. Carvalho AL, Henrique R, Jeronimo C, Nayak CS, Reddy AN, Hoque MO, Chang S, Brait M, Jiang WW, Kim MM, Claybourne Q, Goldenberg D, Khan Z, Khan T, Westra WH, Sidransky D, Koch W, Califano JA. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clin Cancer Res. 2011 Jul 15; 17(14):4782-9.
    View in: PubMed
  58. Karacay H, Sharkey RM, McBride WJ, Rossi EA, Chang CH, Goldenberg DM. Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68Ga. J Nucl Med. 2011 Apr; 52(4):555-9.
    View in: PubMed
  59. Sohrabi S, Drabick JJ, Crist H, Goldenberg D, Sheehan JM, Mackley HB. Neoadjuvant concurrent chemoradiation for advanced esthesioneuroblastoma: a case series and review of the literature. J Clin Oncol. 2011 May 1; 29(13):e358-61.
    View in: PubMed
  60. Alinari L, Yu B, Christian BA, Yan F, Shin J, Lapalombella R, Hertlein E, Lustberg ME, Quinion C, Zhang X, Lozanski G, Muthusamy N, Prætorius-Ibba M, O'Connor OA, Goldenberg DM, Byrd JC, Blum KA, Baiocchi RA. Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma. Blood. 2011 Apr 28; 117(17):4530-41.
    View in: PubMed
  61. Hollenbeak CS, Wang L, Schneider P, Goldenberg D. Outcomes of thyroid cancer in African Americans. Ethn Dis. 2011; 21(2):210-5.
    View in: PubMed
  62. Choby G, Goldenberg D. The history of tracheotomy. Pharos Alpha Omega Alpha Honor Med Soc. 2011; 74(3):34-8.
    View in: PubMed
  63. Negrea GO, Elstrom R, Allen SL, Rai KR, Abbasi RM, Farber CM, Teoh N, Horne H, Wegener WA, Goldenberg DM. Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphoma. Haematologica. 2011 Apr; 96(4):567-73.
    View in: PubMed
  64. Gold DV, Stein R, Burton J, Goldenberg DM. Enhanced expression of CD74 in gastrointestinal cancers and benign tissues. Int J Clin Exp Pathol. 2010; 4(1):1-12.
    View in: PubMed
  65. Newhouse E, Ondik MP, Carr M, Goldenberg D. Who is performing percutaneous tracheotomies? Practice patterns of surgeons in the USA. Eur Arch Otorhinolaryngol. 2011 Mar; 268(3):415-8.
    View in: PubMed
  66. Goldenberg D. Percutaneous tracheotomy and otolaryngology: perceptions, trends and educational implications for our profession. Clin Otolaryngol. 2010 Oct; 35(5):445-6.
    View in: PubMed
  67. Gupta P, Goldenberg DM, Rossi EA, Chang CH. Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias. Blood. 2010 Oct 28; 116(17):3258-67.
    View in: PubMed
  68. Ondik MP, McGinn J, Ruggiero F, Goldenberg D. Unintentional parathyroidectomy and hypoparathyroidism in secondary central compartment surgery for thyroid cancer. Head Neck. 2010 Apr; 32(4):462-6.
    View in: PubMed
  69. Mitchell RM, Eisele DW, Mitzner R, Goldenberg D. The tracheotomy punch for urgent tracheotomy. Laryngoscope. 2010 Apr; 120(4):745-8.
    View in: PubMed
  70. Choby G, Trojanowski A, Johnson S, Goldenberg D. Use of double electrode pads for intraoperative monitoring of the recurrent laryngeal nerve. Ann Otol Rhinol Laryngol. 2010 Apr; 119(4):233-5.
    View in: PubMed
  71. Choby G, Hollenbeak CS, Johnson S, Goldenberg D. Surface electrode recurrent laryngeal nerve monitoring during thyroid surgery: normative values. J Clin Neurophysiol. 2010 Feb; 27(1):34-7.
    View in: PubMed
  72. Mitchell RM, Eisele DW, Goldenberg D. The tracheotomy punch for urgent tracheotomy. Laryngoscope. 2010; 120 Suppl 4:S198.
    View in: PubMed
  73. Pistrio A , Goldenberg D. Current Radiopharmaceuticals. CT-MIBI-SPECT Fusion Imaging Combined with Gamma Probe for. 2010; 3:263-266.
  74. McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN, Goldenberg D. Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis. BMC Cancer. 2009; 9:369.
    View in: PubMed
  75. Ondik MP, Dezfoli S, Lipinski L, Ruggiero F, Goldenberg D. Secondary central compartment surgery for thyroid cancer. Laryngoscope. 2009 Oct; 119(10):1947-50.
    View in: PubMed
  76. Pichardo-Lowden A, Durvesh S, Douglas S, Todd W, Bruno M, Goldenberg D. Anaplastic thyroid carcinoma in a young woman: a rare case of survival. Thyroid. 2009 Jul; 19(7):775-9.
    View in: PubMed
  77. Adil E, Adil T, Fedok F, Kauffman G, Goldenberg D. Minimally invasive radioguided parathyroidectomy performed for primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2009 Jul; 141(1):34-8.
    View in: PubMed
  78. Modrak DE, Leon E, Goldenberg DM, Gold DV. Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines. Mol Cancer Res. 2009 Jun; 7(6):890-6.
    View in: PubMed
  79. Goldenberg D, Brooksby C, Hollenbeak CS. Age as a determinant of outcomes for patients with oral cancer. Oral Oncol. 2009 Aug; 45(8):e57-61.
    View in: PubMed
  80. Stein R, Smith MR, Chen S, Zalath M, Goldenberg DM. Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell lines. Clin Cancer Res. 2009 Apr 15; 15(8):2808-17.
    View in: PubMed
  81. Mattes MJ, Michel RB, Goldenberg DM, Sharkey RM. Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap. Cancer Biother Radiopharm. 2009 Apr; 24(2):185-93.
    View in: PubMed
  82. Sharkey RM, Karacay H, Johnson CR, Litwin S, Rossi EA, McBride WJ, Chang CH, Goldenberg DM. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma. J Nucl Med. 2009 Mar; 50(3):444-53.
    View in: PubMed
  83. Goldenberg D, Park SS, Carr M. Percutaneous tracheotomy in otolaryngology-head and neck surgery residency training programs. Laryngoscope. 2009 Feb; 119(2):289-92.
    View in: PubMed
  84. Cheung EJ, Wagner H, Botti JJ, Fedok F, Goldenberg D. Advanced oral tongue cancer in a 22-year-old pregnant woman. Ann Otol Rhinol Laryngol. 2009 Jan; 118(1):21-6.
    View in: PubMed
  85. Johnson S, Goldenberg D. Intraoperative monitoring of the recurrent laryngeal nerve during revision thyroid surgery. Otolaryngol Clin North Am. 2008 Dec; 41(6):1147-54, ix.
    View in: PubMed
  86. Ort S, Goldenberg D. Management of regional metastases in well-differentiated thyroid cancer. Otolaryngol Clin North Am. 2008 Dec; 41(6):1207-18, xi.
    View in: PubMed
  87. Ondik MP, Tulchinsky M, Goldenberg D. Radioguided reoperative thyroid and parathyroid surgery. Otolaryngol Clin North Am. 2008 Dec; 41(6):1185-98, x.
    View in: PubMed
  88. Goldenberg D. Preface. Revision endocrine surgery of the head and neck. Otolaryngol Clin North Am. 2008 Dec; 41(6):xv-xvi.
    View in: PubMed
  89. Sharkey RM, Goldenberg DM. Novel radioimmunopharmaceuticals for cancer imaging and therapy. Curr Opin Investig Drugs. 2008 Dec; 9(12):1302-16.
    View in: PubMed
  90. Leonard JP, Schuster SJ, Emmanouilides C, Couture F, Teoh N, Wegener WA, Coleman M, Goldenberg DM. Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma. Cancer. 2008 Nov 15; 113(10):2714-23.
    View in: PubMed
  91. Goldenberg D, Zagon IS, Fedok F, Crist HS, McLaughlin PJ. Expression of opioid growth factor (OGF)-OGF receptor (OGFr) axis in human nonmedullary thyroid cancer. Thyroid. 2008 Nov; 18(11):1165-70.
    View in: PubMed
  92. Ondik MP, Kang J, Bayerl MG, Bruno M, Goldenberg D. Teflon laryngeal granuloma presenting as laryngeal cancer on combined positron emission tomography and computed tomography scanning. J Laryngol Otol. 2009 May; 123(5):575-8.
    View in: PubMed
  93. Rossi EA, Goldenberg DM, Cardillo TM, Stein R, Wang Y, Chang CH. Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics. Cancer Res. 2008 Oct 15; 68(20):8384-92.
    View in: PubMed
  94. Raetz EA, Cairo MS, Borowitz MJ, Blaney SM, Krailo MD, Leil TA, Reid JM, Goldenberg DM, Wegener WA, Carroll WL, Adamson PC. Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study. J Clin Oncol. 2008 Aug 1; 26(22):3756-62.
    View in: PubMed
  95. Agrawal N, Goldenberg D. Primary and salvage total laryngectomy. Otolaryngol Clin North Am. 2008 Aug; 41(4):771-80, vii.
    View in: PubMed
  96. Goldenberg D, Begum S, Westra WH, Khan Z, Sciubba J, Pai SI, Califano JA, Tufano RP, Koch WM. Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck. 2008 Jul; 30(7):898-903.
    View in: PubMed
  97. Sharkey RM, Karacay H, Litwin S, Rossi EA, McBride WJ, Chang CH, Goldenberg DM. Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody. Cancer Res. 2008 Jul 1; 68(13):5282-90.
    View in: PubMed
  98. Gold DV, Goldenberg DM, Karacay H, Rossi EA, Chang CH, Cardillo TM, McBride WJ, Sharkey RM. A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma. Cancer Res. 2008 Jun 15; 68(12):4819-26.
    View in: PubMed
  99. Goldenberg D. Announcing the otolaryngology-head and neck surgery section of the Medscape Journal of Medicine. Medscape J Med. 2008; 10(4):104.
    View in: PubMed
  100. Mattes MJ, Goldenberg DM. Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons. Eur J Nucl Med Mol Imaging. 2008 Jul; 35(7):1249-58.
    View in: PubMed
  101. Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, Chang S, Brait M, Nayak CS, Jiang WW, Claybourne Q, Tokumaru Y, Lee J, Goldenberg D, Garrett-Mayer E, Goodman S, Moon CS, Koch W, Westra WH, Sidransky D, Califano JA. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res. 2008 Jan 1; 14(1):97-107.
    View in: PubMed
  102. Gold DV, Karanjawala Z, Modrak DE, Goldenberg DM, Hruban RH. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Clin Cancer Res. 2007 Dec 15; 13(24):7380-7.
    View in: PubMed
  103. Goldenberg DM, Rossi EA, Sharkey RM, McBride WJ, Chang CH. Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting. J Nucl Med. 2008 Jan; 49(1):158-63.
    View in: PubMed
  104. Stein R, Mattes MJ, Cardillo TM, Hansen HJ, Chang CH, Burton J, Govindan S, Goldenberg DM. CD74: a new candidate target for the immunotherapy of B-cell neoplasms. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 2):5556s-5563s.
    View in: PubMed
  105. Scurry WC, Goldenberg D, Chee MY, Lengerich EJ, Liu Y, Fedok FG. Regional recurrence of squamous cell carcinoma of the nasal cavity: a systematic review and meta-analysis. Arch Otolaryngol Head Neck Surg. 2007 Aug; 133(8):796-800.
    View in: PubMed
  106. Bhatti N, Tatlipinar A, Mirski M, Koch WM, Goldenberg D. Percutaneous dilation tracheotomy in intensive care unit patients. Otolaryngol Head Neck Surg. 2007 Jun; 136(6):938-41.
    View in: PubMed
  107. Leonard JP, Goldenberg DM. Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies. Oncogene. 2007 May 28; 26(25):3704-13.
    View in: PubMed
  108. Farrag TY, Koch WM, Cummings CW, Goldenberg D, Abou-Jaoude PM, Califano JA, Flint PW, Webster K, Tufano RP. Supracricoid laryngectomy outcomes: The Johns Hopkins experience. Laryngoscope. 2007 Jan; 117(1):129-32.
    View in: PubMed
  109. Bhatti N, Mirski M, Tatlipinar A, Koch WM, Goldenberg D. Reduction of complication rate in percutaneous dilation tracheostomies. Laryngoscope. 2007 Jan; 117(1):172-5.
    View in: PubMed
  110. Jiang WW, Zahurak M, Goldenberg D, Milman Y, Park HL, Westra WH, Koch W, Sidransky D, Califano J. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer. 2006 Dec 1; 119(11):2673-6.
    View in: PubMed
  111. Goldenberg DM. Adjuvant and combined radioimmunotherapy: problems and prospects on the road to Minerva. J Nucl Med. 2006 Nov; 47(11):1746-8.
    View in: PubMed
  112. Goldenberg DM. Epratuzumab in the therapy of oncological and immunological diseases. Expert Rev Anticancer Ther. 2006 Oct; 6(10):1341-53.
    View in: PubMed
  113. Waldman EH, Goldenberg D, Califano J, Sciubba J, Tunkel DE. Venous malformation of the sternomastoid muscle. Otolaryngol Head Neck Surg. 2006 Aug; 135(2):325-7.
    View in: PubMed
  114. Goldenberg D, Sciubba J, Koch WM. Cystic metastasis from head and neck squamous cell cancer: a distinct disease variant? Head Neck. 2006 Jul; 28(7):633-8.
    View in: PubMed
  115. Carnahan J, Stein R, Qu Z, Hess K, Cesano A, Hansen HJ, Goldenberg DM. Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab. Mol Immunol. 2007 Feb; 44(6):1331-41.
    View in: PubMed
  116. Stein R, Qu Z, Chen S, Solis D, Hansen HJ, Goldenberg DM. Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab. Blood. 2006 Oct 15; 108(8):2736-44.
    View in: PubMed
  117. Wolpoe ME, Goldenberg D, Koch WM. Squamous cell carcinoma of the sinonasal cavity arising as a second primary in individuals with head and neck cancer. Laryngoscope. 2006 May; 116(5):696-9.
    View in: PubMed
  118. Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Ferrer L, Faivre-Chauvet A, Campion L, Vuillez JP, Devillers A, Chang CH, Goldenberg DM, Chatal JF, Barbet J. Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. J Nucl Med. 2006 Feb; 47(2):247-55.
    View in: PubMed
  119. Sharkey RM, Goldenberg DM. Advances in radioimmunotherapy in the age of molecular engineering and pretargeting. Cancer Invest. 2006 Feb; 24(1):82-97.
    View in: PubMed
  120. Ha PK, Hdeib A, Goldenberg D, Jacene H, Patel P, Koch W, Califano J, Cummings CW, Flint PW, Wahl R, Tufano RP. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006 Jan; 132(1):12-6.
    View in: PubMed
  121. Goldenberg DM, Sharkey RM, Paganelli G, Barbet J, Chatal JF. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy. J Clin Oncol. 2006 Feb 10; 24(5):823-34.
    View in: PubMed
  122. Gold DV, Modrak DE, Ying Z, Cardillo TM, Sharkey RM, Goldenberg DM. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol. 2006 Jan 10; 24(2):252-8.
    View in: PubMed
  123. Karacay H, Brard PY, Sharkey RM, Chang CH, Rossi EA, McBride WJ, Ragland DR, Horak ID, Goldenberg DM. Therapeutic advantage of pretargeted radioimmunotherapy using a recombinant bispecific antibody in a human colon cancer xenograft. Clin Cancer Res. 2005 Nov 1; 11(21):7879-85.
    View in: PubMed
  124. Sharkey RM, Cardillo TM, Rossi EA, Chang CH, Karacay H, McBride WJ, Hansen HJ, Horak ID, Goldenberg DM. Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. Nat Med. 2005 Nov; 11(11):1250-5.
    View in: PubMed
  125. Blumenthal RD, Hansen HJ, Goldenberg DM. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res. 2005 Oct 1; 65(19):8809-17.
    View in: PubMed
  126. Sharkey RM, Karacay H, Cardillo TM, Chang CH, McBride WJ, Rossi EA, Horak ID, Goldenberg DM. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods. Clin Cancer Res. 2005 Oct 1; 11(19 Pt 2):7109s-7121s.
    View in: PubMed
  127. Qu Z, Griffiths GL, Wegener WA, Chang CH, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM. Development of humanized antibodies as cancer therapeutics. Methods. 2005 May; 36(1):84-95.
    View in: PubMed
  128. Stein R, Govindan SV, Hayes M, Griffiths GL, Hansen HJ, Horak ID, Goldenberg DM. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody. Clin Cancer Res. 2005 Apr 1; 11(7):2727-34.
    View in: PubMed
  129. Masasyesva BG, Tong BC, Brock MV, Pilkington T, Goldenberg D, Sidransky D, Harden S, Westra WH, Califano J. Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer. Int J Cancer. 2005 Mar 1; 113(6):1022-5.
    View in: PubMed
  130. Golz A, Netzer A, Westerman ST, Westerman LM, Gilbert DA, Joachims HZ, Goldenberg D. Reading performance in children with otitis media. Otolaryngol Head Neck Surg. 2005 Mar; 132(3):495-9.
    View in: PubMed
  131. Davison JM, Rosenbaum E, Barrett TL, Goldenberg D, Hoque MO, Sidransky D, Westra WH. Absence of V599E BRAF mutations in desmoplastic melanomas. Cancer. 2005 Feb 15; 103(4):788-92.
    View in: PubMed
  132. Nahas Z, Goldenberg D, Fakhry C, Ewertz M, Zeiger M, Ladenson PW, Wahl R, Tufano RP. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope. 2005 Feb; 115(2):237-43.
    View in: PubMed
  133. Goldenberg D, Lee J, Koch WM, Kim MM, Trink B, Sidransky D, Moon CS. Habitual risk factors for head and neck cancer. Otolaryngol Head Neck Surg. 2004 Dec; 131(6):986-93.
    View in: PubMed
  134. Stein R, Goldenberg DM. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy. Mol Cancer Ther. 2004 Dec; 3(12):1559-64.
    View in: PubMed
  135. Modrak DE, Cardillo TM, Newsome GA, Goldenberg DM, Gold DV. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer. Cancer Res. 2004 Nov 15; 64(22):8405-10.
    View in: PubMed
  136. Goldenberg D, Rosenbaum E, Argani P, Wistuba II, Sidransky D, Thuluvath PJ, Hidalgo M, Califano J, Maitra A. The V599E BRAF mutation is uncommon in biliary tract cancers. Mod Pathol. 2004 Nov; 17(11):1386-91.
    View in: PubMed
  137. Ostrovsky D, Netzer A, Goldenberg D, Joachims HZ, Golz A. Delayed diagnosis of tracheoesophageal prosthesis aspiration. Ann Otol Rhinol Laryngol. 2004 Oct; 113(10):828-9.
    View in: PubMed
  138. Goldenberg D, Sciubba J, Koch W, Tufano RP. Malignant odontogenic tumors: a 22-year experience. Laryngoscope. 2004 Oct; 114(10):1770-4.
    View in: PubMed
  139. Burton JD, Ely S, Reddy PK, Stein R, Gold DV, Cardillo TM, Goldenberg DM. CD74 is expressed by multiple myeloma and is a promising target for therapy. Clin Cancer Res. 2004 Oct 1; 10(19):6606-11.
    View in: PubMed
  140. Stein R, Qu Z, Cardillo TM, Chen S, Rosario A, Horak ID, Hansen HJ, Goldenberg DM. Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. Blood. 2004 Dec 1; 104(12):3705-11.
    View in: PubMed
  141. Goldenberg D, Benoit NE, Begum S, Westra WH, Cohen Y, Koch WM, Sidransky D, Califano JA. Epstein-Barr virus in head and neck cancer assessed by quantitative polymerase chain reaction. Laryngoscope. 2004 Jun; 114(6):1027-31.
    View in: PubMed
  142. Cohen Y, Rosenbaum E, Begum S, Goldenberg D, Esche C, Lavie O, Sidransky D, Westra WH. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res. 2004 May 15; 10(10):3444-7.
    View in: PubMed
  143. Stein R, Qu Z, Chen S, Rosario A, Shi V, Hayes M, Horak ID, Hansen HJ, Goldenberg DM. Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma. Clin Cancer Res. 2004 Apr 15; 10(8):2868-78.
    View in: PubMed
  144. Goldenberg D, Sciubba J, Tufano RP. Odontogenic ghost cell carcinoma. Head Neck. 2004 Apr; 26(4):378-81.
    View in: PubMed
  145. Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH, Koch WM, Sidransky D, Califano JA. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004 Jan; 130(1):39-44.
    View in: PubMed
  146. Coleman M, Goldenberg DM, Siegel AB, Ketas JC, Ashe M, Fiore JM, Leonard JP. Epratuzumab: targeting B-cell malignancies through CD22. Clin Cancer Res. 2003 Sep 1; 9(10 Pt 2):3991S-4S.
    View in: PubMed
  147. Gordin A, Ben-Arieh Y, Goldenberg D, Netzer A, Golz A. Extension of nasopharyngeal lymphoma to the middle and external ear. Ann Otol Rhinol Laryngol. 2003 Jul; 112(7):644-6.
    View in: PubMed
  148. Goldenberg D, Golz A, Joachims HZ. The beverage maté: a risk factor for cancer of the head and neck. Head Neck. 2003 Jul; 25(7):595-601.
    View in: PubMed
  149. Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, Gayko U, Cesano A, Goldenberg DM. Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003 Aug 15; 21(16):3051-9.
    View in: PubMed
  150. Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D. Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol. 2003 Jul; 24(4):572-5.
    View in: PubMed
  151. Tsai DE, Maillard I, Schuster SJ, Nasta SD, Porter DL, Klumpp TR, Goldenberg DM, Luger SM, Alavi A, Sharkey RM, Hartzell KB, Stadtmauer EA. Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody. Clin Lymphoma. 2003 Jun; 4(1):56-9.
    View in: PubMed
  152. Golz A, Goldenberg D, Netzer A, Fradis M, Westerman ST, Westerman LM, Joachims HZ. Paper patching for chronic tympanic membrane perforations. Otolaryngol Head Neck Surg. 2003 Apr; 128(4):565-70.
    View in: PubMed
  153. Goldenberg D, Golz A, Huri A, Netzer A, Joachims HZ, Bar-Lavie Y. Percutaneous dilation tracheotomy versus surgical tracheotomy: our experience. Otolaryngol Head Neck Surg. 2003 Mar; 128(3):358-63.
    View in: PubMed
  154. Kaidar-Person O, Golz A, Netzer A, Goldsher D, Joachims HZ, Goldenberg D. Rapidly progressive bilateral sensory neural hearing loss as a presentation of mitochondrial neurogastrointestinal encephalomyopathy. Am J Otolaryngol. 2003 Mar-Apr; 24(2):128-30.
    View in: PubMed
  155. O'Hara JA, Blumenthal RD, Grinberg OY, Grinberg S, Wilmot C, Goldenberg DM, Swartz HM. Tumor pO2 assessments in human xenograft tumors measured by EPR oximetry: location of paramagnetic materials. Adv Exp Med Biol. 2003; 530:205-14.
    View in: PubMed
  156. Goldenberg D. Maté: a risk factor for oral and oropharyngeal cancer. Oral Oncol. 2002 Oct; 38(7):646-9.
    View in: PubMed
  157. Goldenberg D, Golz A, Netzer A, Joachims HZ. Tracheotomy: changing indications and a review of 1,130 cases. J Otolaryngol. 2002 Aug; 31(4):211-5.
    View in: PubMed
  158. Gordin A, Goldenberg D, Golz A, Netzer A, Joachims HZ. Magnesium: a new therapy for idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2002 Jul; 23(4):447-51.
    View in: PubMed
  159. Goldenberg D, Golz A, Netzer A, Joachims HZ. The use of otic powder in the treatment of acute external otitis. Am J Otolaryngol. 2002 May-Jun; 23(3):142-7.
    View in: PubMed
  160. Goldenberg DM. Targeted therapy of cancer with radiolabeled antibodies. J Nucl Med. 2002 May; 43(5):693-713.
    View in: PubMed
  161. Goldenberg DM. Eighth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. Introduction. Cancer. 2002 Feb 15; 94(4 Suppl):1193-5.
    View in: PubMed
  162. Modrak DE, Rodriguez MD, Goldenberg DM, Lew W, Blumenthal RD. Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts. Int J Oncol. 2002 Feb; 20(2):379-84.
    View in: PubMed
  163. Netzer A, Golz A, Goldenberg D, Silberman M, Joachims HZ. Hyposmia following laryngectomy: experimental model. J Otolaryngol. 2002 Feb; 31(1):9-12.
    View in: PubMed
  164. Duek SD, Goldenberg D, Linn S, Krausz MM, Hershko DD. The role of fine-needle aspiration and intraoperative frozen section in the surgical management of solitary thyroid nodules. Surg Today. 2002; 32(10):857-61.
    View in: PubMed
  165. Goldenberg D, Wenig BL. Telemedicine in otolaryngology. Am J Otolaryngol. 2002 Jan-Feb; 23(1):35-43.
    View in: PubMed
  166. Goldenberg D, Golz A, Netzer A, Flax-Goldenberg R, Joachims HZ. Synergistic necrotizing cellulitis as a complication of peritonsillar abscess. Am J Otolaryngol. 2001 Nov-Dec; 22(6):415-9.
    View in: PubMed
  167. Golz A, Netzer A, Goldenberg D, Westerman ST, Westerman LM, Joachims HZ. The association between iron-deficiency anemia and recurrent acute otitis media. Am J Otolaryngol. 2001 Nov-Dec; 22(6):391-4.
    View in: PubMed
  168. Golz A, Westerman ST, Westerman LM, Goldenberg D, Netzer A, Wiedmyer T, Fradis M, Joachims HZ. The effects of noise on the vestibular system. Am J Otolaryngol. 2001 May-Jun; 22(3):190-6.
    View in: PubMed
  169. Goldenberg D, Golz A, Netzer A, Rosenblatt E, Rachmiel A, Goldenberg RF, Joachims HZ. Epstein-Barr virus and cancers of the head and neck. Am J Otolaryngol. 2001 May-Jun; 22(3):197-205.
    View in: PubMed
  170. Goldenberg D, Golz A, Fradis M, Mârtu D, Netzer A, Joachims HZ. Malignant tumors of the nose and paranasal sinuses: a retrospective review of 291 cases. Ear Nose Throat J. 2001 Apr; 80(4):272-7.
    View in: PubMed
  171. Golz A, Goldenberg D, Netzer A, Westerman ST, Joachims HZ. Epiglottic carcinoma presenting as obstructive sleep apnea. J Otolaryngol. 2001 Feb; 30(1):58-9.
    View in: PubMed
  172. Luntz M, Brodsky A, Nusem S, Kronenberg J, Keren G, Migirov L, Cohen D, Zohar S, Shapira A, Ophir D, Fishman G, Rosen G, Kisilevsky V, Magamse I, Zaaroura S, Joachims HZ, Goldenberg D. Acute mastoiditis--the antibiotic era: a multicenter study. Int J Pediatr Otorhinolaryngol. 2001 Jan; 57(1):1-9.
    View in: PubMed
  173. Golz A, Goldenberg D, Westerman ST, Catalfumo FJ, Netzer A, Westerman LM, Joachims HZ. Laser partial epiglottidectomy as a treatment for obstructive sleep apnea and laryngomalacia. Ann Otol Rhinol Laryngol. 2000 Dec; 109(12 Pt 1):1140-5.
    View in: PubMed
  174. Goldenberg D, Flax-Goldenberg R, Joachims HZ, Peled N. Misplaced parotid glands: bilateral agenesis of parotid glands associated with bilateral accessory parotid tissue. J Laryngol Otol. 2000 Nov; 114(11):883-5.
    View in: PubMed
  175. Lechner P, Lind P, Goldenberg DM. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival? J Am Coll Surg. 2000 Nov; 191(5):511-8.
    View in: PubMed
  176. Golz A, Goldenberg D, Ben-Arie Y, Keren R, Netzer A, Westerman ST, Joachims HZ. Basal cell adenocarcinoma of the parotid gland presenting as a retroauricular abscess. Am J Otolaryngol. 2000 Nov-Dec; 21(6):421-6.
    View in: PubMed
  177. Goldenberg D, Ari EG, Golz A, Danino J, Netzer A, Joachims HZ. Tracheotomy complications: a retrospective study of 1130 cases. Otolaryngol Head Neck Surg. 2000 Oct; 123(4):495-500.
    View in: PubMed
  178. Goldenberg D, Gilboa M, Danino J, Flax-Goldenberg R, Miller B, Joachims HZ. A large ethmoido-orbital osteoma presenting with epiphora in an 11-year-old boy. J Pediatr Ophthalmol Strabismus. 2000 Jul-Aug; 37(4):238-40.
    View in: PubMed
  179. Goldenberg D, Danino J, Netzer A, Joachims HZ. Plastipore implants in the surgical treatment of atrophic rhinitis: technique and results. Otolaryngol Head Neck Surg. 2000 Jun; 122(6):794-7.
    View in: PubMed
  180. Tsai DE, Schuster SJ, Matthies A, Moore HC, Alavi A, Juweid ME, Goldenberg DM, Stadtmauer EA. Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy. Clin Lymphoma. 2000 Jun; 1(1):62-6.
    View in: PubMed
  181. Goldenberg D, Karam M, Netzer A, Galamidi Z, Golz A, Golsovsky M, Joachims HZ. Facial vein thrombophlebitis: A rare but potentially lethal entity. Otolaryngol Head Neck Surg. 2000 May; 122(5):769-71.
    View in: PubMed
  182. Goldenberg D, Ardekian L, Rachmiel A, Peled M, Joachims HZ, Laufer D. Carcinoma of the dorsum of the tongue. Head Neck. 2000 Mar; 22(2):190-4.
    View in: PubMed
  183. Goldenberg D, Rachmiel A, Ben Yitzhak O, Peled M, Golz A, Laufer D, Joachims HZ. Triple primary malignancies of the head and neck. J Otolaryngol. 2000 Feb; 29(1):51-4.
    View in: PubMed
  184. Danino J, Goldenberg D, Joachims HZ. Submucosal arytenoidectomy: new surgical technique and review of the literature. J Otolaryngol. 2000 Feb; 29(1):13-6.
    View in: PubMed
  185. Goldenberg D, Flax-Goldenberg R, Joachims HZ, Peled N. Quiz case 1. Congenital nasal pyriform aperture stenosis (CNPAS). Arch Otolaryngol Head Neck Surg. 2000 Jan; 126(1):94, 96.
    View in: PubMed
  186. Goldenberg D, Golz A, Arie YB, Joachims HZ. Adenocarcinoma of the rectum with metastasis to the palatine tonsil. Otolaryngol Head Neck Surg. 1999 Nov; 121(5):653-4.
    View in: PubMed
  187. Stein R, Juweid M, Zhang CH, Goldenberg DM. Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3199s-3206s.
    View in: PubMed
  188. Juweid ME, Zhang CH, Blumenthal RD, Hajjar G, Sharkey RM, Goldenberg DM. Prediction of hematologic toxicity after radioimmunotherapy with (131)I-labeled anticarcinoembryonic antigen monoclonal antibodies. J Nucl Med. 1999 Oct; 40(10):1609-16.
    View in: PubMed
  189. Goldenberg DM. Introduction to the Seventh Conference on Radioimmunodetection and Radioimmunodetection and Radioimmunotherapy of Cancer. Clin Cancer Res. 1999 Oct; 5(10 Suppl):2991s.
    View in: PubMed
  190. Ong GL, Goldenberg DM, Hansen HJ, Mattes MJ. Cell surface expression and metabolism of major histocompatibility complex class II invariant chain (CD74) by diverse cell lines. Immunology. 1999 Oct; 98(2):296-302.
    View in: PubMed
  191. Patel S, Stein R, Ong GL, Goldenberg DM, Mattes MJ. Enhancement of tumor-to-nontumor localization ratios by hepatocyte-directed blood clearance of antibodies labeled with certain residualizing radiolabels. J Nucl Med. 1999 Aug; 40(8):1392-401.
    View in: PubMed
  192. Golz A, Goldenberg D, Netzer A, Westerman LM, Westerman ST, Fradis M, Joachims HZ. Cholesteatomas associated with ventilation tube insertion. Arch Otolaryngol Head Neck Surg. 1999 Jul; 125(7):754-7.
    View in: PubMed
  193. Barron B, Hanna C, Passalaqua AM, Lamki L, Wegener WA, Goldenberg DM. Rapid diagnostic imaging of acute, nonclassic appendicitis by leukoscintigraphy with sulesomab, a technetium 99m-labeled antigranulocyte antibody Fab' fragment. LeukoScan Appendicitis Clinical Trial Group. Surgery. 1999 Mar; 125(3):288-96.
    View in: PubMed
  194. Goldenberg D, Karam M, Danino J, Flax-Goldenberg R, Joachims HZ. Temporal bone fracture following blunt trauma caused by a flying fish. J Laryngol Otol. 1998 Oct; 112(10):959-61.
    View in: PubMed
  195. Catalfumo FJ, Golz A, Westerman ST, Gilbert LM, Joachims HZ, Goldenberg D. The epiglottis and obstructive sleep apnoea syndrome. J Laryngol Otol. 1998 Oct; 112(10):940-3.
    View in: PubMed
  196. Reddy N, Ong GL, Behr TM, Sharkey RM, Goldenberg DM, Mattes MJ. Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations. Cancer Immunol Immunother. 1998 Mar; 46(1):25-33.
    View in: PubMed
  197. Juweid ME, Zhang CH, Blumenthal RD, Sharkey RM, Dunn R, Dunlop D, Goldenberg DM. Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodies. Cancer. 1997 Dec 15; 80(12 Suppl):2749-53.
    View in: PubMed
  198. Behr TM, Sharkey RM, Sgouros G, Blumenthal RD, Dunn RM, Kolbert K, Griffiths GL, Siegel JA, Becker WS, Goldenberg DM. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry. Cancer. 1997 Dec 15; 80(12 Suppl):2591-610.
    View in: PubMed
  199. Goldenberg DM. Perspectives on oncologic imaging with radiolabeled antibodies. Cancer. 1997 Dec 15; 80(12 Suppl):2431-5.
    View in: PubMed
  200. Blumenthal RD, Alisauskas R, Juweid M, Sharkey RM, Goldenberg DM. Defining the optimal spacing between repeat radioantibody doses in experimental models: is there an accurate measurement for hematopoietic recovery? Cancer. 1997 Dec 15; 80(12 Suppl):2624-35.
    View in: PubMed
  201. Goldenberg D, Golz A, Flax-Goldenberg R, Joachims HZ. Severe laryngeal injury caused by blunt trauma to the neck: a case report. J Laryngol Otol. 1997 Dec; 111(12):1174-6.
    View in: PubMed
  202. Stein R, Goldenberg DM, Ong GL, Thorpe SR, Mattes MJ. Manipulation of blood clearance to optimize delivery of residualizing label-antibody conjugates to tumor cells in vivo. J Nucl Med. 1997 Sep; 38(9):1392-400.
    View in: PubMed
  203. Blumenthal RD, Sharkey RM, Haywood L, Behr T, Goldenberg DM. Application of cytokine intervention for improved radio-antibody dose delivery. Int J Cancer. 1997 Jul 3; 72(1):166-73.
    View in: PubMed
  204. Dresel S, Kirsch CM, Tatsch K, Zachoval R, Hahn K, Goldenberg DM. Detection of hepatocellular carcinoma with a new alpha-fetoprotein antibody imaging kit. J Clin Oncol. 1997 Jul; 15(7):2683-90.
    View in: PubMed
  205. Goldenberg D, Golz A, Joachims HZ. Retropharyngeal abscess: a clinical review. J Laryngol Otol. 1997 Jun; 111(6):546-50.
    View in: PubMed
  206. Behr TM, Sharkey RM, Juweid ME, Dunn RM, Vagg RC, Ying Z, Zhang CH, Swayne LC, Vardi Y, Siegel JA, Goldenberg DM. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. J Nucl Med. 1997 Jun; 38(6):858-70.
    View in: PubMed
  207. Mattes MJ, Shih LB, Govindan SV, Sharkey RM, Ong GL, Xuan H, Goldenberg DM. The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody. Int J Cancer. 1997 May 2; 71(3):429-35.
    View in: PubMed
  208. Goldenberg D, Gatot A, Barki Y, Leiberman A, Fliss DM. Computerized tomographic and ultrasonographic features of Kimura's disease. J Laryngol Otol. 1997 Apr; 111(4):389-91.
    View in: PubMed
  209. Behr TM, Sharkey RM, Juweid ME, Dunn RM, Ying Z, Zhang CH, Siegel JA, Goldenberg DM. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. J Nucl Med. 1997 Mar; 38(3):409-18.
    View in: PubMed
  210. Stein R, Goldenberg DM, Thorpe SR, Mattes MJ. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung. J Nucl Med. 1997 Mar; 38(3):391-5.
    View in: PubMed
  211. Juweid M, Sharkey RM, Alavi A, Swayne LC, Herskovic T, Hanley D, Rubin AD, Pereira M, Goldenberg DM. Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody. J Nucl Med. 1997 Feb; 38(2):257-60.
    View in: PubMed
  212. Goldenberg DM, Wegener W. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group. Acta Med Austriaca. 1997; 24(2):55-9.
    View in: PubMed
  213. Juweid ME, Sharkey RM, Behr T, Swayne LC, Dunn R, Siegel J, Goldenberg DM. Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2. J Nucl Med. 1996 Sep; 37(9):1504-10.
    View in: PubMed
  214. Blumenthal RD, Stein R, Sharkey RM, Goldenberg DM, Ong GL, Klein KM, Mattes MJ. Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colon. Cancer Res. 1996 Aug 1; 56(15):3508-15.
    View in: PubMed
  215. Moffat FL, Pinsky CM, Hammershaimb L, Petrelli NJ, Patt YZ, Whaley FS, Goldenberg DM. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group. J Clin Oncol. 1996 Aug; 14(8):2295-305.
    View in: PubMed
  216. Juweid M, Sharkey RM, Behr TM, Swayne LC, Dunn R, Ying Z, Siegel JA, Hansen HJ, Goldenberg DM. Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2. Cancer. 1996 Jul 1; 78(1):157-68.
    View in: PubMed
  217. Behr TM, Becker WS, Sharkey RM, Juweid ME, Dunn RM, Bair HJ, Wolf FG, Goldenberg DM. Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. J Nucl Med. 1996 May; 37(5):829-33.
    View in: PubMed
  218. Juweid M, Sharkey RM, Behr T, Swayne LC, Rubin AD, Herskovic T, Hanley D, Markowitz A, Dunn R, Siegel J, Kamal T, Goldenberg DM. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. J Clin Oncol. 1996 Apr; 14(4):1209-17.
    View in: PubMed
  219. Shih LB, Xuan H, Aninipot R, Stein R, Goldenberg DM. In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer. Cancer Res. 1995 Dec 1; 55(23 Suppl):5857s-5863s.
    View in: PubMed
  220. Juweid M, Sharkey RM, Siegel JA, Behr T, Goldenberg DM. Estimates of red marrow dose by sacral scintigraphy in radioimmunotherapy patients having non-Hodgkin's lymphoma and diffuse bone marrow uptake. Cancer Res. 1995 Dec 1; 55(23 Suppl):5827s-5831s.
    View in: PubMed
  221. Juweid M, Sharkey RM, Behr T, Swayne LC, Rubin AD, Hanley D, Herskovic T, Markowitz A, Siegel J, Goldenberg DM. Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigen. Cancer Res. 1995 Dec 1; 55(23 Suppl):5946s-5951s.
    View in: PubMed
  222. Blumenthal RD, Sharkey RM, Forman D, Wong G, Hess J, Goldenberg DM. Improved experimental cancer therapy by radioantibody dose intensification as a result of syngeneic bone marrow transplantation. Exp Hematol. 1995 Sep; 23(10):1088-97.
    View in: PubMed
  223. Behr TM, Sharkey RM, Juweid ME, Blumenthal RD, Dunn RM, Griffiths GL, Bair HJ, Wolf FG, Becker WS, Goldenberg DM. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res. 1995 Sep 1; 55(17):3825-34.
    View in: PubMed
  224. Stein R, Goldenberg DM, Thorpe SR, Basu A, Mattes MJ. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors. Cancer Res. 1995 Jul 15; 55(14):3132-9.
    View in: PubMed
  225. Grossman J, Hirsch J, Goldenberg D, Libby S, Fendrich M, Mackesy-Amiti ME, Mazur C, Chance GH. Strategies for school-based response to loss: proactive training and postvention consultation. Crisis. 1995; 16(1):18-26.
    View in: PubMed
  226. Kramer EL, Noz ME, Liebes L, Murthy S, Tiu S, Goldenberg DM. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results. Cancer. 1994 Feb 1; 73(3 Suppl):890-5.
    View in: PubMed
  227. Stein R, Basu A, Goldenberg DM, Lloyd KO, Mattes MJ. Characterization of cluster 13: the epithelial/carcinoma antigen recognized by MAb RS7. Int J Cancer Suppl. 1994; 8:98-102.
    View in: PubMed
  228. Goldenberg DM. Monoclonal antibodies in cancer detection and therapy. Am J Med. 1993 Mar; 94(3):297-312.
    View in: PubMed
  229. Stein R, Witz IP, Ovadia J, Goldenberg DM, Yron I. CD5+ B cells and naturally occurring autoantibodies in cancer patients. Clin Exp Immunol. 1991 Sep; 85(3):418-23.
    View in: PubMed
  230. Goldenberg DM, Horowitz JA, Sharkey RM, Hall TC, Murthy S, Goldenberg H, Lee RE, Stein R, Siegel JA, Izon DO, et al. Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody. J Clin Oncol. 1991 Apr; 9(4):548-64.
    View in: PubMed
  231. Varadarajan A, Sharkey RM, Goldenberg DM, Hawthorne MF. Conjugation of phenyl isothiocyanate derivatives of carborane to antitumor antibody and in vivo localization of conjugates in nude mice. Bioconjug Chem. 1991 Mar-Apr; 2(2):102-10.
    View in: PubMed
  232. Goldenberg DM. Cancer imaging and therapy with radiolabeled antibodies. Adv Exp Med Biol. 1991; 303:107-17.
    View in: PubMed
  233. Goldenberg DM, Goldenberg H, Higginbotham-Ford E, Shochat D, Ruoslahti E. Imaging of primary and metastatic liver cancer with 131I monoclonal and polyclonal antibodies against alphafetoprotein. J Clin Oncol. 1987 Nov; 5(11):1827-35.
    View in: PubMed
  234. DeLand FH, Kim EE, Primus FJ, Dine ME, Goldenberg DM. In vivo radioimmunodetection of occult recurrent colonic carcinoma. AJR Am J Roentgenol. 1982 Jan; 138(1):145-8.
    View in: PubMed
  235. Kim EE, Corgan RL, Casper S, Primus FJ, Spremulli E, Estes N, Goldenberg DM. Axillary lymphoscintigraphy by radioimmunodetection of carcinoembryonic antigen in breast cancer. J Nucl Med. 1979 Dec; 20(12):1243-50.
    View in: PubMed
  236. Donaldson E, Van Nagell JR, Wood EG, Pletsch Q, Goldenberg DM. Carcinoembryonic antigen in patients treated with radiation therapy for invasive squamous cell carcinoma of the uterine cervix. AJR Am J Roentgenol. 1976 Nov; 127(5):829-31.
    View in: PubMed
  237. Goldenberg DM, Pant KD. Host immunoreactivity to CSA, a tissue-specific antigen of normal and neoplastic human intestine. Adv Exp Med Biol. 1976; 73 Pt B:351-6.
    View in: PubMed
Goldenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_